Jaclyn LoPiccolo, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nelfinavir | 5 | 2021 | 68 | 1.100 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 2 | 2017 | 77 | 0.630 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2018 | 242 | 0.550 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2019 | 329 | 0.480 |
Why?
|
| Prednisone | 1 | 2018 | 1567 | 0.440 |
Why?
|
| Sexual Dysfunctions, Psychological | 10 | 1986 | 193 | 0.410 |
Why?
|
| Proto-Oncogene Proteins c-akt | 7 | 2017 | 2456 | 0.400 |
Why?
|
| Lung Neoplasms | 7 | 2024 | 13499 | 0.400 |
Why?
|
| Protein Multimerization | 1 | 2015 | 965 | 0.350 |
Why?
|
| GTP-Binding Protein gamma Subunits | 2 | 2017 | 22 | 0.280 |
Why?
|
| GTP-Binding Protein beta Subunits | 2 | 2017 | 35 | 0.270 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2007 | 115 | 0.260 |
Why?
|
| Genomic Structural Variation | 1 | 2025 | 80 | 0.230 |
Why?
|
| Sexual Dysfunction, Physiological | 7 | 1991 | 364 | 0.220 |
Why?
|
| HIV Protease Inhibitors | 3 | 2014 | 430 | 0.220 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11873 | 0.220 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2023 | 102 | 0.200 |
Why?
|
| Smoke | 1 | 2024 | 242 | 0.190 |
Why?
|
| Metatarsophalangeal Joint | 1 | 2001 | 41 | 0.190 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2007 | 1120 | 0.190 |
Why?
|
| Orgasm | 8 | 1986 | 62 | 0.190 |
Why?
|
| Protein Kinases | 1 | 2007 | 1610 | 0.180 |
Why?
|
| Antineoplastic Agents | 6 | 2023 | 13658 | 0.170 |
Why?
|
| Camptothecin | 1 | 2023 | 599 | 0.170 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 5861 | 0.170 |
Why?
|
| Chloroquine | 1 | 2021 | 276 | 0.160 |
Why?
|
| Gene Amplification | 1 | 2023 | 1088 | 0.160 |
Why?
|
| Pneumocystis carinii | 1 | 2018 | 72 | 0.150 |
Why?
|
| Pinocytosis | 1 | 2017 | 63 | 0.150 |
Why?
|
| Marital Therapy | 4 | 1986 | 44 | 0.140 |
Why?
|
| Neuroblastoma | 1 | 2025 | 1266 | 0.130 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2017 | 246 | 0.130 |
Why?
|
| Germ-Line Mutation | 1 | 2025 | 1883 | 0.130 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 760 | 0.130 |
Why?
|
| Apoptosis | 4 | 2021 | 9521 | 0.120 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2015 | 42 | 0.120 |
Why?
|
| Penile Erection | 3 | 1992 | 100 | 0.120 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2015 | 47 | 0.120 |
Why?
|
| Protein Structure, Quaternary | 1 | 2015 | 426 | 0.120 |
Why?
|
| Erectile Dysfunction | 5 | 1992 | 437 | 0.110 |
Why?
|
| Penis | 2 | 1992 | 209 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2015 | 2884 | 0.110 |
Why?
|
| Receptor, erbB-2 | 1 | 2023 | 2601 | 0.100 |
Why?
|
| Administration, Oral | 2 | 2018 | 4030 | 0.100 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 8535 | 0.100 |
Why?
|
| Catalytic Domain | 1 | 2015 | 699 | 0.100 |
Why?
|
| Bronchoscopy | 1 | 2018 | 913 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2025 | 2564 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3609 | 0.100 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 696 | 0.100 |
Why?
|
| Phosphorylcholine | 1 | 2012 | 153 | 0.100 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2012 | 201 | 0.100 |
Why?
|
| Secretory Vesicles | 1 | 2012 | 128 | 0.100 |
Why?
|
| Cell Line, Tumor | 6 | 2021 | 17128 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 622 | 0.090 |
Why?
|
| Ceramides | 1 | 2012 | 203 | 0.090 |
Why?
|
| Humans | 43 | 2025 | 767991 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2023 | 5394 | 0.090 |
Why?
|
| Autophagy | 2 | 2007 | 1349 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2166 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 2012 | 751 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3771 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 5799 | 0.080 |
Why?
|
| Signal Transduction | 5 | 2017 | 23642 | 0.080 |
Why?
|
| Sexual Behavior | 10 | 1991 | 2197 | 0.070 |
Why?
|
| Boronic Acids | 1 | 2012 | 915 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2021 | 10470 | 0.070 |
Why?
|
| Smoking | 1 | 2024 | 9089 | 0.070 |
Why?
|
| Marriage | 6 | 1985 | 351 | 0.070 |
Why?
|
| Pyrazines | 1 | 2012 | 1205 | 0.070 |
Why?
|
| Genes, ras | 1 | 2009 | 657 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10757 | 0.070 |
Why?
|
| Libido | 3 | 1985 | 124 | 0.060 |
Why?
|
| Neoplasms | 3 | 2014 | 22365 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2025 | 18062 | 0.060 |
Why?
|
| Psychotherapy, Multiple | 1 | 1985 | 7 | 0.060 |
Why?
|
| Psychotherapy | 3 | 1985 | 1655 | 0.060 |
Why?
|
| Male | 26 | 2025 | 364641 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5335 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2007 | 1750 | 0.060 |
Why?
|
| Counseling | 1 | 1991 | 1554 | 0.050 |
Why?
|
| Liver | 1 | 2018 | 7574 | 0.050 |
Why?
|
| HEK293 Cells | 3 | 2017 | 4289 | 0.050 |
Why?
|
| Adult | 18 | 2025 | 223583 | 0.050 |
Why?
|
| Drug Design | 1 | 2007 | 1045 | 0.050 |
Why?
|
| Behavior Therapy | 3 | 1982 | 886 | 0.050 |
Why?
|
| Sex Education | 1 | 1982 | 94 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2007 | 1133 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 2004 | 0.050 |
Why?
|
| Masturbation | 3 | 1975 | 8 | 0.040 |
Why?
|
| Risk Factors | 2 | 2025 | 74936 | 0.040 |
Why?
|
| Germ Cells | 1 | 2023 | 644 | 0.040 |
Why?
|
| Female | 25 | 2025 | 397113 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2007 | 2061 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 39345 | 0.040 |
Why?
|
| Psychological Tests | 3 | 1979 | 643 | 0.040 |
Why?
|
| Aged | 6 | 2023 | 171446 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2025 | 1777 | 0.040 |
Why?
|
| Animals | 10 | 2023 | 169222 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 20757 | 0.040 |
Why?
|
| Ejaculation | 3 | 1986 | 59 | 0.040 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2017 | 163 | 0.030 |
Why?
|
| Caspases | 2 | 2012 | 882 | 0.030 |
Why?
|
| Lipids | 1 | 2007 | 3342 | 0.030 |
Why?
|
| Immunoconjugates | 1 | 2023 | 975 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2007 | 2230 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2012 | 3620 | 0.030 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2015 | 31 | 0.030 |
Why?
|
| Spodoptera | 1 | 2015 | 140 | 0.030 |
Why?
|
| Peptides | 1 | 2007 | 4354 | 0.030 |
Why?
|
| Lysophospholipids | 1 | 2017 | 338 | 0.030 |
Why?
|
| Immobilized Proteins | 1 | 2015 | 24 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 3114 | 0.030 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2015 | 87 | 0.030 |
Why?
|
| Guanosine Diphosphate | 1 | 2015 | 79 | 0.030 |
Why?
|
| Middle Aged | 10 | 2023 | 223422 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 1977 | 1001 | 0.030 |
Why?
|
| Maryland | 1 | 2014 | 278 | 0.030 |
Why?
|
| Protein Binding | 2 | 2017 | 9343 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2012 | 2392 | 0.030 |
Why?
|
| RNA Interference | 2 | 2012 | 2830 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 3428 | 0.030 |
Why?
|
| Chromatin | 1 | 2025 | 2981 | 0.030 |
Why?
|
| Psychosexual Development | 1 | 1972 | 19 | 0.030 |
Why?
|
| Sex Factors | 3 | 2025 | 10627 | 0.030 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2012 | 83 | 0.020 |
Why?
|
| Social Values | 1 | 1973 | 224 | 0.020 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2012 | 62 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2014 | 897 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2017 | 3587 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 8052 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2023 | 3443 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2012 | 287 | 0.020 |
Why?
|
| Mice | 5 | 2023 | 82024 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2023 | 3589 | 0.020 |
Why?
|
| Equipment and Supplies | 1 | 1992 | 274 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2012 | 384 | 0.020 |
Why?
|
| Arousal | 2 | 1986 | 1179 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 1973 | 498 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2023 | 12536 | 0.020 |
Why?
|
| Personality | 1 | 1972 | 559 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 1760 | 0.020 |
Why?
|
| Elongation Factor 2 Kinase | 1 | 2007 | 10 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 2906 | 0.020 |
Why?
|
| Prevalence | 1 | 2023 | 15867 | 0.020 |
Why?
|
| Virilism | 1 | 1966 | 28 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4857 | 0.020 |
Why?
|
| Norethindrone | 1 | 1966 | 56 | 0.020 |
Why?
|
| Attitude | 3 | 1979 | 771 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2014 | 65364 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 6515 | 0.020 |
Why?
|
| Personal Satisfaction | 3 | 1985 | 643 | 0.010 |
Why?
|
| Mutation | 1 | 2009 | 30211 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1966 | 454 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1992 | 13000 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2023 | 12165 | 0.010 |
Why?
|
| Manuals as Topic | 1 | 1982 | 99 | 0.010 |
Why?
|
| Sirolimus | 1 | 2009 | 1538 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2025 | 42665 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 1625 | 0.010 |
Why?
|
| Testis | 1 | 1985 | 783 | 0.010 |
Why?
|
| Professional-Patient Relations | 1 | 1986 | 724 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1985 | 707 | 0.010 |
Why?
|
| Pyridines | 1 | 2012 | 2893 | 0.010 |
Why?
|
| Time Factors | 2 | 2014 | 40214 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 6231 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 9556 | 0.010 |
Why?
|
| Child | 1 | 2025 | 80906 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 59598 | 0.010 |
Why?
|
| Coitus | 1 | 1975 | 132 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1992 | 20218 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 81746 | 0.010 |
Why?
|
| Cognition | 1 | 1972 | 7072 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2012 | 5196 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2006 | 10098 | 0.010 |
Why?
|
| Family | 1 | 1985 | 3210 | 0.010 |
Why?
|
| Research | 1 | 1982 | 1979 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11068 | 0.010 |
Why?
|
| Love | 1 | 1973 | 39 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1975 | 1625 | 0.010 |
Why?
|
| Methods | 1 | 1972 | 1066 | 0.010 |
Why?
|
| MMPI | 1 | 1972 | 81 | 0.010 |
Why?
|
| Thematic Apperception Test | 1 | 1972 | 40 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 19017 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2006 | 11221 | 0.010 |
Why?
|
| Role | 1 | 1972 | 176 | 0.010 |
Why?
|
| Homosexuality | 1 | 1972 | 269 | 0.010 |
Why?
|
| Fixation, Ocular | 1 | 1972 | 243 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18344 | 0.010 |
Why?
|
| Social Perception | 1 | 1973 | 435 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 60048 | 0.000 |
Why?
|
| Estrus | 1 | 1966 | 70 | 0.000 |
Why?
|
| Castration | 1 | 1966 | 149 | 0.000 |
Why?
|
| Self Concept | 1 | 1972 | 1043 | 0.000 |
Why?
|
| Prognosis | 1 | 2006 | 29979 | 0.000 |
Why?
|
| Pregnancy, Animal | 1 | 1966 | 124 | 0.000 |
Why?
|
| Interpersonal Relations | 1 | 1973 | 1434 | 0.000 |
Why?
|
| Genitalia | 1 | 1966 | 114 | 0.000 |
Why?
|
| Psychometrics | 1 | 1974 | 3062 | 0.000 |
Why?
|
| Visual Perception | 1 | 1972 | 1402 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1984 | 384 | 0.000 |
Why?
|
| Uterus | 1 | 1966 | 663 | 0.000 |
Why?
|
| Ovary | 1 | 1966 | 965 | 0.000 |
Why?
|
| Emotions | 1 | 1973 | 2766 | 0.000 |
Why?
|
| Organ Size | 1 | 1966 | 2267 | 0.000 |
Why?
|
| Animals, Newborn | 1 | 1966 | 2678 | 0.000 |
Why?
|
| Rats | 1 | 1966 | 23751 | 0.000 |
Why?
|
| Adolescent | 1 | 1973 | 89155 | 0.000 |
Why?
|
| Pregnancy | 1 | 1966 | 30260 | 0.000 |
Why?
|